Jason Chesney
Molecular Targets Group
Medical Oncology
James Graham Brown Cancer Center
University of Louisville
USA
Name/email consistency: high
- 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Chesney, J. Curr. Opin. Clin. Nutr. Metab. Care (2006)
- Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality. Chesney, J., Telang, S., Yalcin, A., Clem, A., Wallis, N., Bucala, R. Biochem. Biophys. Res. Commun. (2005)